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Background: Abdominal aortic aneurysm (AAA) is characterized is characterized by the destruction of tissue architecture due to chronic 
inflammation of unknown etiology. Emerging clinical evidence showed the effectiveness of angiotensin-converting enzyme inhibitor (ACEI) on the 
progression of AAA more than angiotensin II receptor blockers, although the underlying mechanism has not been fully elucidated.
Methods: We investigated the effects of ACEI, imidapril (10mg/kg/say, n =10), angiotensin II receptor blocker, losartan (10mg/kg/say, n =10), and 
hydralazine (30mg/kg/day, n =10) on CaCl2-induced AAA in mice. Saline-treated mice was served as controls.
Result: Six week after CaCl2-treatment, imidapril significantly prevented the enlargement of aorta compared to treatments with an angiotensin 
II receptor blocker, losartan and hydralazine. (28%, 60% and 84%, respectively, p< 0.01). Blood pressure was significantly and equally lowered 
among three groups. The elevated expressions of MCP-1 and TNF-alpha and the recruitment of macrophages to AAA lesion were significantly 
reduced in imidapril-treated mice compared to losartan and hydralazine-treated mice. The in situ gelatin zymographies showed that lower matrix 
metalloproteinase (MMP)-2 and MMP-9 activities in AAA in imidapril treated mice compared with losartan and hydralazine treated mice. In addition, 
in vitro experiment, imidapril significantly reduced the activities of MMPs from AAA tissue and cultured smooth muscle cells more than that in 
losartan, even after the addition of serine protease inhibitors.
Conclusion: Imidapril attenuated the development of AAA more than losartan in mice. The direct inhibitory action of MMPs in imidapril may 
contribute to the protection of dilatation of aorta.
